Proteome Sciences plc (PRM.L)

3,5000 +0,2000 (+6,06%) Alla chiusura: 02:53PM BST

Proteome Sciences plc

Coveham House
Downside Bridge Road
Cobham KT11 3EP
United Kingdom
44 20 7043 2116
https://www.proteomics.com

Settore/i: Healthcare
Settore: Diagnostics & Research
Impiegati a tempo pieno: 35

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Dr. Mariola Sohngen	CEO & Executive Director	310k	N/D	1961
Mr. Abdelghani Omari	CFO & Director	209k	N/D	1976
Dr. Ian H. Pike	Chief Scientific Officer & Executive Director	233k	N/D	1964
Mr. Richard Paul Dennis	Chief Commercial Officer & Executive Director	235k	N/D	1958
Mr. Glenn Barney	Vice President of Sales & Marketing	N/D	N/D	N/D
Victoria Joanna Birse	Company Secretary	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2022 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in GBp.

Descrizione

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. It offers SysQuant provides comprehensive analysis of protein activity across regulatory and signaling pathways; TMT MS2 for analyzing cells and tissues when no phosphopeptide enrichment is required; and TMT MS3, a method for biomarker discovery in plasma and other complex samples where quantitative accuracy is the important factor. The company also provides TMT Calibrator that analyzes diseased or treated tissue in parallel with peripheral fluids; TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates; and SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers, as well as bioinformatics tools. It primarily serves pharmaceutical and biotechnology companies, and academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.

Governance aziendale

L'ISS Governance QualityScore di Proteome Sciences plc al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.